Adenosine plasma concentration in pulmonary hypertension

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 228-236

  Saadjian, Alain Y ^a,c   Paganelli, Franck ^a   Reynaud Gaubert, Martine L ^a   Levy, Samuel ^a   Guieu, Régis P ^b  

^a HÔPITAL NORD   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

Adenosine; Endothelial function; Hemodynamics; Hypoxia anoxia; Pulmonary circulation

Indexed keywords

ADENOSINE;

ADULT; AGED; ANOXIA; ARTERY CONSTRICTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HUMAN; HYPOXIA; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG ENDOTHELIUM; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; OXYGEN BREATHING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE;

ADENOSINE; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FEMORAL ARTERY; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PULMONARY ARTERY; VASCULAR RESISTANCE;

EID: 0033058773     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00059-0     Document Type: Article

References (50)

1. Shryock J.C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 79:(12A):1997;2-10.
2. Bardenheuer H., Schrader D. Supply to demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol. 250:1986;H173-H180.
3. Schlüter H., Offers E., Bruggemann G., et al. Diadenosine phosphates and the physiological control of blood pressure. Nature. 367:1994;186-188.
4. Reeves J.T., Groves B.M., Weir E.K. Adenosine and selective reduction of pulmonary vascular resistance in primary pulmonary hypertension. Circulation. 84:1991;1437-1438.
5. Morgan J.M., McCormack D.G., Griffiths M.J.D., et al. Adenosine as a vasodilator in primary pulmonary hypertension. Circulation. 84:1991;1145-1149.
6. Schrader B.J., Inbar S., Kaufmann L., Vestal R.E., Rich S. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension. JACC. 19:1992;1060-1064.
7. Inbar S., Schrader B.J., Kaufmann L., Vestal R.E., Rich S. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. JACC. 21:1993;413-418.
8. Nootens M., Schrader B.J., Kaufmann L., et al. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. Chest. 107:1995;54-57.
9. Kneussl M.P., Lang I.M., Brenot F.P. Medical management of primary pulmonary hypertension. Eur Respir J. 9:1996;2401-2409.
10. Fullerton D.A., Jones S.D., Grover F.L., McIntyre R.C. Jr. Adenosine effectively controls pulmonary hypertension after cardiac operations. Ann Thorac Surg. 61:1996;1118-1123.
11. Klabunde R.E., Althouse D.G. Adenosine metabolism in dog whole blood: effects of dipyridamole. Life Sci. 23:1981;2631-2641.
12. Klabunde R.E. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol. 93:1983;21-26.
13. Moser G.H., Schrader J., Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 256:1989;C799-C806.
14. Shryock J.C., Boykin M.T., Hill J.A., Bellardinelli L. A new method for sampling blood for measurement of plasma adenosine. Am J Physiol. 258:1990;H1232-H1239.
15. Ontyd J., Schrader J. Measurement of adenosine, inosine and hypoxanthine in human plasma. J Chromatogr. 307:1984;404-409.
16. Guieu R., Sampieri F., Bechis G., Rochat H. Use of HPLC to measure circulating adenosine levels in migrainous patients. Clin Chim Acta. 227:1994;185-194.
17. Guieu R., Paganelli F., Sampieri F., et al. The use of HPLC to evaluate the variations of blood coronary adenosine levels during percutaneous transluminal angioplasty. Clin Chim Acta. 230:1994;63-68.
18. Rich S., Dantzker D.R., Ayers S.M., et al. Primary pulmonary hypertension: A prospective study. Ann Intern Med. 107:1987;216-223.
19. Guieu R., Sampieri F., Bechis G., Rochat H. Adenosine in painful legs and moving toes syndrome. Clin Neuropharmacol. 5:1994;460-469.
20. Guieu R., Peragut J.C., Roussel P., et al. Adenosine and neuropathic pain. Pain. 68:1996;1-5.
21. Maseri A., Crea F., Kaski J.C., Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 17:1991;499-506.
22. Cannon R.O., Camici P.G., Epstein S.E. Pathophysiological dilemma of syndrome X. Circulation. 85:1992;883-892.
23. Rosano G.M., Lindsay D.C., Poole-Wilson P.A. Syndrome X: an hypothesis for cardiac pain without ischaemia. Cardiologia. 36:1991;885-895.
24. Lagerqvist B., Sylven C., Helmius G., Waldenstrom A. Effects of exogenous adenosine in a patient with transplanted heart. Evidence for adenosine as a messenger in angina pectoris. Ups J Med Sci. 95:1990;137-145.
25. Catravas J.D. Removal of adenosine from the rabbit pulmonary circulation, in vivo and in vitro. Circ Res. 54:1984;603-611.
26. Griffiths M., Beaumont N., Yao S., et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med. 3:1997;89-93.
27. Sollevi A. Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol. 27:1986;319-349.
28. Watt A.H., Routledge P.A. Adenosine stimulates respiration in man. Br J Clin Pharmacol. 20:1985;503-506.
29. Bush A., Busst C.M., Clarke B., Barnes P.J. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. Br J Clin Pharmacol. 27:1989;165-171.
30. Reid P.G., Fraser A.G., Watt A.H., Henderson A.H., Routeledge P.A. Acute haemodyamic effects of intravenous infusion of adenosine in conscious man. Eur Heart J. 11:1990;1018-1028.
31. Pearl R.G. Adenosine produces pulmonary vasodilatation in the perfused rabbit lung via A2 receptor. Anest Analg. 79:1994;46-51.
32. Haynes J., Obiako B., Thomson W.J., Downey J. Adenosine-induced vasodilatation: receptor characterization in pulmonary circulation. Am J Physiol. 268:1995;H1862-H1868.
33. Biaggioni I., King L.S., Enayat N., Robertson D., Newman J.M. Adenosine produces pulmonary vasoconstriction in sheep: evidence for thromboxane A2 prostaglandins endoperoxidase receptor activation. Circ Res. 65:1989;1516-1525.
34. Cheng D.Y., Dewitt B.J., Suzuki F., Neely C.F., Kadowitz P.J. Adenosine A1 and A2 receptors mediate tone dependent responses in feline pulmonary vascular bed. Am J Physiol. 270:1996;H200-H207.
35. Jolin A., Helset E., Tollali T., Bjertnaes L.J. Adenosine modulates vascular resistance and fluid filtration in isolated rat lungs. Acta Anaesthesiol Scand. 36:1992;400-405.
36. Thomas T., Marshall J.M. The role of adenosine in hypoxic pulmonary vasoconstriction in the anaesthetized rat. Exp Physiol. 78:1993;541-543.
37. Jolin A., Kjaeve J., Helset E., et al. Evidence against endogenously released adenosine as modulator of the pressor response to hypoxia in isolated rat lungs. Acta Anaesthesiol Scand. 36:1992;449-453.
38. Pelleg A., Porter S. The pharmacology of adenosine. Pharmacotherapy. 10:1990;157-174.
39. Olsson R.A., Pearson J.D. Cardiovascular purinoreceptors. Physiol Rev. 70:1990;761-845.
40. Feigl E.O. Coronary Physiology. Physiol Rev. 63:1983;1-205.
41. Mentzer R.M. Jr., Rubio R., Berne R.M. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol. 229:1975;1625-1631.
42. Lopes A.A., Maeda N.Y., Bydlowski S.P. Abnomalities in circulating von Willebrand factor and survival in pulmonary hypertension. Am J Med. 105:1998;21-26.
43. Brett S.J., Gibbs J.S.R., Pepper J.R., Evans T.W. Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension. Thorax. 51:1996;89-91.
44. Le Cras T.D., Tyler R.C., Horan M.P., et al. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. J Clin Invest. 101:1998;795-801.
45. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest. 114:1998;208S-212S.
46. A receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension. Circulation. 97:1998;2169-2174.
47. Parks W.C., Mecham R.P., Crouch E.C., Orton E.C., Stenmark K.R. Response to lobar vessels to hypoxic pulmonary hypertension. Am Rev Respir Dis. 140:1989;1455-1457.
48. Pearson J.D., Gordon J.L. Vascular endothelium and smooth muscle cells in culture selectively release adenine nucleotides. Nature. 281:1979;384-386.
49. Dubey R.K., Gillespie D.G., Mi Z., Jackson E.K. Adenosine inhibits growth of human aortic smooth muscle cells via A2b receptors. Hypertension. 31:(part 2):1998;516-521.
50. Jackson E.K., Koelher M., Mi Z., et al. Possible role of adenosine deaminase in vaso-occlusive diseases. J Hypertens. 17:1998;19-29.